Patent · US Active

Use of the non-opiate analgesic drug flupirtine for the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowel syndrome

US7309713B2 · kind B2 · utility

14Cited by

12References

27Claims

0Family size

Assignee

elbion GmbH · DE

Inventors

Chris Rundfeldt · Coswig, DE
Hildegard Kuss · Dresden, DE
Regina Draheim · Radebeul, DE
Katrin Bernoester · Radebeul, DE

Key dates

Filing date	Jan 20, 2006
Grant date	Dec 18, 2007
Priority date	—
Expiry date	Jul 29, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P13/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to the prevention, reversal and medical treatment of lower urinary tract dysfunction including bladder instability and other related diseases as described below including urinary flow problems, urgency and incontinence as a result of prostate hyperplasia (BPH) and to the prevention, reversal and medical treatment of irritable bowl syndrome (IBS) with special focus on the diarrhea-predominant and mixed diarrhea-constipation type IBS, both in human beings and animals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.